Efficacy of Lafutidine Versus Famotidine in Patients with Reflux Esophagitis: A Multi-Center, Randomized, Double-Blind, Non-inferiority Phase III Trial
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, Eun Hye | - |
dc.contributor.author | Lee, Yong Chan | - |
dc.contributor.author | Chang, Young Woon | - |
dc.contributor.author | Park, Jong-Jae | - |
dc.contributor.author | Chun, Hoon Jai | - |
dc.contributor.author | Jung, Hwoon-Yong | - |
dc.contributor.author | Kim, Hyun-Soo | - |
dc.contributor.author | Jeong, Hyun Yong | - |
dc.contributor.author | Seol, Sang-Young | - |
dc.contributor.author | Han, Sok Won | - |
dc.contributor.author | Choi, Myung-Gyu | - |
dc.contributor.author | Park, Soo-Heon | - |
dc.contributor.author | Lee, Ok-Jae | - |
dc.contributor.author | Jung, Jin Tae | - |
dc.contributor.author | Lee, Dong Ho | - |
dc.contributor.author | Jung, Hyun Chae | - |
dc.contributor.author | Lee, Soo Teik | - |
dc.contributor.author | Kim, Jae Gyu | - |
dc.contributor.author | Youn, Sei Jin | - |
dc.contributor.author | Kim, Hak Yang | - |
dc.contributor.author | Lee, Sang Woo | - |
dc.date.available | 2019-03-08T20:37:31Z | - |
dc.date.issued | 2015-06 | - |
dc.identifier.issn | 0163-2116 | - |
dc.identifier.issn | 1573-2568 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/11351 | - |
dc.description.abstract | Background: There has been no study on the efficacy of lafutidine for patients with reflux esophagitis in Korea. Aim: To evaluate the efficacy of a new-generation histamine-2 receptor antagonist, lafutidine, in comparison with famotidine in patients with reflux esophagitis. Methods: This was a randomized, double-blind, non-inferiority trial enrolling patients with erosive esophagitis. The efficacy and safety of 20 mg lafutidine (treatment group) were compared with those of 40 mg famotidine (control group) and 20 mg omeprazole (reference group). The primary endpoint was the complete healing rates of reflux esophagitis on endoscopy after 8 weeks of treatment. The non-inferiority margin was assumed to be −15 %. Results: The healing rates of reflux esophagitis on endoscopy after 8 weeks of treatment were 70.14 % (101/144) in the lafutidine, 63.45 % (92/145) in the famotidine, and 85.71 % (126/147) in the omeprazole group. The difference in healing rates between the lafutidine and famotidine groups was 6.69 % (95 % confidence interval = [−4.14 to 17.52]). In addition, lafutidine was superior to famotidine in clinical improvement (53.73 % vs. 39.55 %, P = 0.0200). Conclusions: Lafutidine was non-inferior to famotidine in healing of reflux esophagitis. Lafutidine, however, was superior to famotidine in terms of symptom relief of reflux esophagitis. © 2014, Springer Science+Business Media New York. | - |
dc.format.extent | 9 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | Springer New York LLC | - |
dc.title | Efficacy of Lafutidine Versus Famotidine in Patients with Reflux Esophagitis: A Multi-Center, Randomized, Double-Blind, Non-inferiority Phase III Trial | - |
dc.type | Article | - |
dc.identifier.doi | 10.1007/s10620-014-3489-4 | - |
dc.identifier.bibliographicCitation | Digestive Diseases and Sciences, v.60, no.6, pp 1724 - 1732 | - |
dc.description.isOpenAccess | N | - |
dc.identifier.wosid | 000355580800028 | - |
dc.identifier.scopusid | 2-s2.0-84930380654 | - |
dc.citation.endPage | 1732 | - |
dc.citation.number | 6 | - |
dc.citation.startPage | 1724 | - |
dc.citation.title | Digestive Diseases and Sciences | - |
dc.citation.volume | 60 | - |
dc.type.docType | Article | - |
dc.publisher.location | 네델란드 | - |
dc.subject.keywordAuthor | Famotidine | - |
dc.subject.keywordAuthor | Lafutidine | - |
dc.subject.keywordAuthor | Omeprazole | - |
dc.subject.keywordAuthor | Reflux esophagitis | - |
dc.relation.journalResearchArea | Gastroenterology & Hepatology | - |
dc.relation.journalWebOfScienceCategory | Gastroenterology & Hepatology | - |
dc.description.journalRegisteredClass | sci | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
84, Heukseok-ro, Dongjak-gu, Seoul, Republic of Korea (06974)02-820-6194
COPYRIGHT 2019 Chung-Ang University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.